Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPRAZOLAM vs ALPROSTADIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPRAZOLAM vs ALPROSTADIL: Safety Overview

Metric ALPRAZOLAM ALPROSTADIL
Total FAERS Reports 48,357 2,800
Deaths Reported 16,072 60
Death Rate 33.2% 2.1%
Hospitalizations 15,996 210
Average Patient Age 48.1 yrs 62.5 yrs
% Female Patients 60.4% 4.9%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Endo USA, Inc. ENDO USA, Inc.
Route ORAL INTRACAVERNOUS
Marketing Status Prescription Prescription